STAR Advisory Board

The CMTA’s STAR Advisory Board comprises a Scientific Advisory Board, a Therapy Expert Board and a Clinical Expert Board.

The Scientific Advisory Board (SAB) provides scientific input for ongoing or proposed projects and evaluates:

  • The scientific status of current CMTA-funded research, identifying the scientific basis of target strategies for each CMT subtype.
  • Research proposals for their scientific background and the soundness of the research strategy.
  • The progress of research teams, recommending changes in research strategies as needed.

The Therapy Expert Board (TEB) evaluates the translational quality of ongoing and proposed projects and examines:

  • The pharmacological approach of disease area project team efforts.
  • The potential to form strategic alliances with pharmaceutical partners.
  • The preclinical strategy, particularly its contribution to clinical testing approaches.

The TEB may also take an active role in managing and monitoring strategic alliances.

The Clinical Expert Board (CEB) provides expert guidance and support to the CMTA’s alliance partners, helping to assure the success of clinical trials by:

  • Providing the natural history and clinical expertise to design, develop and enable clinical trials.
  • Collaborating with scientists in the development of clinical biomarkers.
  • Ensuring the adequate recruitment of carefully evaluated patients and experienced investigators to conduct these trials.

Membership

SAB

TEB

CEB

John Svaren

John Svaren, PhD, SAB Chair

University of Wisconsin

checkmark_blue_200x200
Frank Baas

Frank Baas, MD, PhD

University of Amsterdam,
The Netherlands

checkmark_blue_200x200
Robert H. Baloh

Robert H. Baloh, MD, PhD

Cedars-Sinai Medical Center

checkmark_blue_200x200
M. Laura Feltri

M. Laura Feltri, MD

University at Buffalo

checkmark_blue_200x200
Gabsang Lee

Gabsang Lee, PhD

Johns Hopkins University

checkmark_blue_200x200
Jun Li

Jun Li, MD, PhD

Vanderbilt University

checkmark_blue_200x200
Rudolph Martini

Rudolph Martini, PhD

University of Würzburg, Germany

checkmark_blue_200x200
Albee Messing

Albee Messing, VMD, PhD

University of Wisconsin

checkmark_blue_200x200
Klaus-Armin Nave

Klaus-Armin Nave, PhD

Max Planck Institute for Experimental Medicine
University of Göttingen, Germany

checkmark_blue_200x200
Brian Popko

Brian Popko, MD

University of Chicago

checkmark_blue_200x200
Mario Saporta

Mario Saporta, MD, PhD

University of Miami

checkmark_blue_200x200
Steven S. Scherer

Steven S. Scherer, MD, PhD

University of Pennsylvania

checkmark_blue_200x200 checkmark_blue_200x200
Lawrence Wrabetz

Lawrence Wrabetz, MD

University at Buffalo

checkmark_blue_200x200
Stephan Zuchner

Stephan Züchner, MD, PhD

University of Miami

checkmark_blue_200x200
Mark Scheideler

Mark Scheideler, PhD, TEB Chair

HumanFirst Therapeutics LLC

checkmark_blue_200x200
David Herrmann

David Herrmann, MD

University of Rochester

checkmark_blue_200x200 checkmark_blue_200x200
Tage Honore

Tage Honore, PhD

Aestus Therapeutics Inc.

checkmark_blue_200x200
Christopher Klein

Christopher Klein, MD

Mayo Clinic, Rochester, Minnesota

checkmark_blue_200x200 checkmark_blue_200x200
Lars J. Knutsen

Lars J. S. Knutsen, PhD

Discovery Pharma Consulting LLC

checkmark_blue_200x200
Claes Wahlestedt

Claes Wahlestedt, MD, PhD

University of Miami

checkmark_blue_200x200
Michael E. Shy

Michael E. Shy, MD, CEB Chair

University of Iowa

checkmark_blue_200x200
Mary Reilly

Mary Reilly, MD, CEB Co-Chair

National Hospital, London, England

checkmark_blue_200x200
Richard Finkel

Richard Finkel, MD

Nemour’s Children’s Hospital, Orlando, Florida

checkmark_blue_200x200
Davide Pareyson

Davide Pareyson, MD

Besta Institute, Milan, Italy

checkmark_blue_200x200
Joshua Burns

Joshua Burns, PhD

University of Sydney, Australia

checkmark_blue_200x200
Michael McDermott

Michael McDermott, PhD, Consultant

University of Rochester Medical Center

checkmark_blue_200x200

STAR Advisory Board Confidentiality and Conflict of Interest Policy

Each member of the STAR Advisory Board is required to abide by the CMTA’s Confidentiality and Conflict of Interest Policy: CMTA_STAR_Advisory_Board_Confidentiality_COI_Policy1.pdf